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Since 2006 there have been 6 reported cases of altered visual acuity and intracranial pressure (ICP) in 
long duration astronauts. In order to document this risk and develop an integrated approach to its 
mitigation, the NASA Space Life Sciences Directorate (SLSD) and Human Research Program (HRP) have 
chosen to use the Human System Risk Board (HSRB) and the risk management analysis tool (RMAT). The 
HSRB is the venue in which the stakeholders and customers discuss and vet the evidence and the RMAT 
is the tool that facilitates documentation and comparison of the evidence across mission profiles as well 
as identification of risk factors, and documentation of mitigation strategies. This process allows for 
information to be brought forward and dispositioned so that it may be properly incorporated into the 
RMAT and contribute to the design of the research and mitigation plans. The evidence thus far has 
resulted in the identification of a visual impairment/intracranial pressure (VIIP) project team, updating 
of both short and long duration medical requirements designed to assess visual acuity, and a research 
plan to characterize this issue further. In order to understand this issue more completely, a plan to 
develop an Accelerated Research Collaboration (ARC) has been approved by the HSRB. The ARC is a 
novel research model pioneered by the Myelin Repair Foundation. It is a patient centered research 
model that brings together researchers and clinicians, under the guidance of a scientific advisory panel, 
to collaborate and produce results much quickly than accomplished through traditional research 
models. The data and evidence from the updated medical requirements and the VIIP ARC will be 
reviewed at the HSRB on a regular basis. Each review package presented to the HSRB will include an 
assessment and recommendation with respect to continuation of research, countermeasure 
development, occupational surveillance modalities, selection criteria, etc. This process will determine 
the course of the VIIP project and ultimately how SLSD and HRP mitigate this emerging human health 
and performance risk.  
https://ntrs.nasa.gov/search.jsp?R=20100036630 2019-08-30T12:09:28+00:00Z
